Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0O1UX
|
|||
| Former ID |
DIB001691
|
|||
| Drug Name |
Peanut allergy desensitization vaccine
|
|||
| Synonyms |
VIASKIN Peanut; DBV-712; Peanut allergy desensitization vaccine (VIASKIN); Peanut allergy desensitization vaccine (VIASKIN), DBV
Click to Show/Hide
|
|||
| Indication | Allergy [ICD-11: 4A80-4A85; ICD-10: T78.4; ICD-9: 995.3] | Phase 3 | [1] | |
| Hypersensitivity [ICD-11: 4A80-4A85; ICD-10: T78.4] | Phase 2 | [2] | ||
| Company |
Dbv technologies
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | ClinicalTrials.gov (NCT01904604) Peanut Epicutaneous Phase II Immunotherapy Clinical Trial. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.